Cargando…
Risk Factors for Intracerebral Hemorrhage in Patients With Atrial Fibrillation on Non–Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention
BACKGROUND AND PURPOSE: Clinical trials on stroke prevention in patients with atrial fibrillation have consistently shown clinical benefit from either warfarin or non–vitamin K antagonist oral anticoagulants (NOACs). NOAC-treated patients have consistently reported to be at lower risk for intracereb...
Ejemplares similares
-
Rates and Determinants for the Use of Anticoagulation Treatment before Stroke in Patients with Known Atrial Fibrillation
por: Giustozzi, Michela, et al.
Publicado: (2020) -
Response: Aortic Stiffness in Patients with Deep and Lobar Intracerebral Hemorrhage: Role of Antihypertensive Drugs and Statins
por: Acampa, Maurizio, et al.
Publicado: (2015) -
Frequency and determinants for hemorrhagic transformation of posterior cerebral stroke: Posterior ischemic stroke and hemorrhagic transformation
por: Valentino, Francesca, et al.
Publicado: (2017) -
Ischemic Stroke after Heart Transplantation
por: Acampa, Maurizio, et al.
Publicado: (2016) -
Clinical Onset and Multiple Sclerosis Relapse after SARS-CoV-2 Infection
por: Pignolo, Antonia, et al.
Publicado: (2021)